Stem cell therapy for central nervous system demyelinating disease

被引：14
作者：
Manganas L.N. [1 ]
Maletic-Savatic M. [1 ]
机构：
[1] Department of Neurology, Stony Brook University, Stony Brook
来源：
Current Neurology and Neuroscience Reports | 2005年 / 5卷 / 3期
关键词：
Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Neural Stem Cell; Stem Cell Therapy; Bone Marrow Stem Cell;
D O I：
10.1007/s11910-005-0050-z
中图分类号：
学科分类号：
摘要：
Recent advances in cell-based therapies for demyelinating central nervous system diseases have demonstrated the ability to restore damaged neuronal architecture and function. Demyelinated axons in patients with multiple sclerosis can spontaneously remyelinate over time; however, the rate and extent at which remyelination occurs is inadequate for complete recovery. Previous attempts aimed at regenerating myelin-forming cells have been successful but limited by the multifocal nature of the lesions and the inability to produce large numbers of myelin-producing cells in culture. Stem cell-based therapy can overcome these limitations to some extent and may prove useful in the future treatment of demyelinating diseases. Copyright © 2005 by Current Science Inc.
引用
收藏
页码：225 / 231
页数：6
相关论文
共 50 条
  • [41] A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble?
    Invernizzi, P.
    Bonometti, M. A.
    Turri, E.
    Benedetti, M. D.
    Salviati, A.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (07) : 1003 - 1006
  • [42] Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system
    Zhang, Jing
    Zhang, Zheng Gang
    Li, Yi
    Lu, Mei
    Zhang, Yi
    Elias, Stanton B.
    Chopp, Michael
    NEUROBIOLOGY OF DISEASE, 2016, 88 : 85 - 95
  • [43] Monophasic Acquired Demyelinating Syndromes of the Central Nervous System in Children
    Hardy, Duriel
    SEMINARS IN PEDIATRIC NEUROLOGY, 2023, 46
  • [44] Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders
    Patil, Varsha A.
    Kamat, Saurabh N.
    Lalkaka, Jamshed A.
    Singhal, Bhim
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2021, 24 (05) : 732 - 739
  • [45] Update on pathology of central nervous system inflammatory demyelinating diseases
    Kalinowska-Lyszczarz, Alicja
    Guo, Yong
    Lucchinetti, Claudia F.
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2022, 56 (03) : 201 - 209
  • [46] Auto antibodies in inflammatory demyelinating diseases of the central nervous system
    Lalive, Patrice H.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 692 - 707
  • [47] Hepatitis B vaccine and central nervous system demyelinating diseases
    Halsey, NA
    Duclos, P
    Van Damme, P
    Margolis, H
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (01) : 23 - 24
  • [48] Idiopathic inflammatory-demyelinating diseases of the central nervous system
    Rovira Canellas, A.
    Rovira Gols, A.
    Rio Izquierdo, J.
    Tintore Subirana, M.
    Montalban Gairin, X.
    NEURORADIOLOGY, 2007, 49 (05) : 393 - 409
  • [49] Differential imaging of atypical demyelinating lesions of the central nervous system
    Matteo Paoletti
    Shaun Ivan Muzic
    Francesca Marchetti
    Lisa Maria Farina
    Stefano Bastianello
    Anna Pichiecchio
    La radiologia medica, 2021, 126 : 827 - 842
  • [50] Acquired demyelinating disorders of central nervous system: A pediatric cohort
    Gulati, Sheffali
    Chakrabarty, Biswaroop
    Kumar, Atin
    Jain, Puneet
    Patel, Harsh
    Saini, Lokesh
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2015, 18 : S48 - S55
12345